J. Abels

2.0k total citations
59 papers, 1.6k citations indexed

About

J. Abels is a scholar working on Rheumatology, Hematology and Molecular Biology. According to data from OpenAlex, J. Abels has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 20 papers in Hematology and 15 papers in Molecular Biology. Recurrent topics in J. Abels's work include Folate and B Vitamins Research (18 papers), Acute Myeloid Leukemia Research (15 papers) and Porphyrin Metabolism and Disorders (7 papers). J. Abels is often cited by papers focused on Folate and B Vitamins Research (18 papers), Acute Myeloid Leukemia Research (15 papers) and Porphyrin Metabolism and Disorders (7 papers). J. Abels collaborates with scholars based in Netherlands, United States and Germany. J. Abels's co-authors include A Hagemeijer, K. Hählen, H. O. Nieweg, Jan Lindemans, W Sizoo, Huub H.D.M. van Vliet, M. C. Kappers‐Klunne, Wobbe Bouma, T. H. J. Huisman and J. G. Gilman and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

J. Abels

59 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Abels Netherlands 23 751 435 375 345 271 59 1.6k
F. Maloisel France 18 590 0.8× 225 0.5× 396 1.1× 196 0.6× 113 0.4× 61 1.3k
I. Tatarsky Israel 21 873 1.2× 548 1.3× 455 1.2× 146 0.4× 51 0.2× 94 1.6k
Mogens Krogh Jensen Denmark 20 463 0.6× 263 0.6× 281 0.7× 92 0.3× 252 0.9× 58 1.1k
Donald E. Holdsworth United States 10 331 0.4× 299 0.7× 98 0.3× 759 2.2× 220 0.8× 13 1.2k
Enrico Balleari Italy 23 735 1.0× 399 0.9× 368 1.0× 214 0.6× 150 0.6× 71 1.8k
Andrew Will United Kingdom 21 797 1.1× 328 0.8× 331 0.9× 98 0.3× 154 0.6× 53 1.6k
Roberto Gastaldi Italy 24 351 0.5× 173 0.4× 542 1.4× 144 0.4× 160 0.6× 73 1.7k
Johan Lanng Nielsen Denmark 24 1.3k 1.7× 418 1.0× 612 1.6× 91 0.3× 48 0.2× 63 2.0k
Nasrollah T. Shahidi United States 21 578 0.8× 256 0.6× 372 1.0× 54 0.2× 157 0.6× 47 1.4k
Shigeki Ohtake Japan 27 1.7k 2.3× 480 1.1× 741 2.0× 263 0.8× 787 2.9× 134 2.6k

Countries citing papers authored by J. Abels

Since Specialization
Citations

This map shows the geographic impact of J. Abels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Abels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Abels more than expected).

Fields of papers citing papers by J. Abels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Abels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Abels. The network helps show where J. Abels may publish in the future.

Co-authorship network of co-authors of J. Abels

This figure shows the co-authorship network connecting the top 25 collaborators of J. Abels. A scholar is included among the top collaborators of J. Abels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Abels. J. Abels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abels, J., et al.. (2025). AI-generated cancer prevention influencers can target risk groups on social media at low cost. European Journal of Cancer. 217. 115251–115251. 3 indexed citations
2.
Schipperus, Martin R., et al.. (2008). Interleukin-6 and Interleukin-1 enhancement of GM-CSF-dependent proliferation of haematopoietic progenitor cells in myelodysplastic syndromes. British Journal of Haematology. 77(4). 515–522. 4 indexed citations
3.
Ermens, Anton A. M., Martijn Schoester, Jan Lindemans, & J. Abels. (1991). Effect of nitrous oxide and methotrexate on folate coenzyme pools of blast cells from leukemia patients. Leukemia Research. 15(2-3). 165–171. 9 indexed citations
4.
Ermens, Anton A. M., Helga Refsum, Anne Berit Guttormsen, et al.. (1991). Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine. Clinical Pharmacology & Therapeutics. 49(4). 385–393. 69 indexed citations
5.
Schipperus, Martin R., et al.. (1990). In Vitro Growth Kinetics of Myeloid Progenitor Cells of Myelodysplastic Patients in Response to Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3. Hämatologie und Bluttransfusion. 33. 98–102. 2 indexed citations
6.
Sonneveld, Pieter, et al.. (1990). Clinicopathological diagnosis and treatment of malignant histiocytosis. British Journal of Haematology. 75(4). 511–516. 25 indexed citations
7.
Sonneveld, Pieter, et al.. (1990). Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinoma. Cancer. 65(1). 23–25. 7 indexed citations
8.
Schipperus, Martin R., et al.. (1990). The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells. Leukemia Research. 14(11-12). 1019–1025. 8 indexed citations
9.
Lindemans, Jan, et al.. (1989). Uptake of transcobalamin II-bound cobalamin by HL-60 cells: Effects of differentiation induction. Experimental Cell Research. 184(2). 449–460. 33 indexed citations
10.
Lindemans, Jan, J. Van Kapel, F. Arwert, & J. Abels. (1988). Separation of transcobalamin II isoproteins by means of chromatofocusing. Journal of Chromatography B Biomedical Sciences and Applications. 432. 103–111. 2 indexed citations
11.
Michiels, J. J., et al.. (1988). TdT positive B‐cell acute lymphoblastic leukaemia (B‐ALL) without Burkitt characteristics. British Journal of Haematology. 68(4). 423–426. 19 indexed citations
12.
Schipperus, Martin R., A Hagemeijer, R. E. Ploemacher, et al.. (1988). In myelodysplastic syndromes progression to leukemia is directly related to PHA dependency for colony formation and independent of in vitro maturation capacity.. PubMed. 2(7). 433–7. 8 indexed citations
13.
Vliet, Huub H.D.M. van, et al.. (1987). Antibodies against glycosphingolipids in sera of patients with idiopathic thrombocytopenic purpura. British Journal of Haematology. 67(1). 103–108. 36 indexed citations
14.
Dongen, Jacques J. M. van, Herbert Hooijkaas, K. Hählen, et al.. (1985). Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.. The Journal of Immunology. 135(5). 3144–3150. 78 indexed citations
15.
Boomsma, Frans, et al.. (1983). Angiotensin converting enzyme: a tumour marker in malignant histiocytosis.. BMJ. 286(6371). 1106.1–1106. 5 indexed citations
16.
Kerkhofs, H., A Hagemeijer, C. H. W. Leeksma, et al.. (1982). The 5q‐ chromosome abnormality in haematological disorders:|a collaborative study of 34 cases from the Netheralands. British Journal of Haematology. 52(3). 365–381. 74 indexed citations
17.
Hagemeijer, A, W Sizoo, E.M.E. Smit, & J. Abels. (1981). Translocation (5p;17q) in blast crisis of chronic myeloid leukemia. Cytogenetic and Genome Research. 30(4). 205–210. 2 indexed citations
18.
Löwenberg, Bob, J. Abels, Fritz H. Schröder, & J. A. H. Murray. (1980). MESNUM AND CYCLOPHOSPHAMIDE CYSTITIS. The Lancet. 316(8205). 1195–1195. 4 indexed citations
19.
Abels, J., et al.. (1964). GASTRIC INTRINSIC FACTOR. The Lancet. 283(7327). 271–271. 5 indexed citations
20.
Abels, J., Wobbe Bouma, & H. O. Nieweg. (1963). Assay of intrinsic factor with anti-intrinsic factor serum in vitro. Biochimica et Biophysica Acta. 71. 227–229. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Maloisel Breakdown of academic impact, for papers by I. Tatarsky Breakdown of academic impact, for papers by Mogens Krogh Jensen Breakdown of academic impact, for papers by Donald E. Holdsworth Breakdown of academic impact, for papers by Enrico Balleari Breakdown of academic impact, for papers by Andrew Will Breakdown of academic impact, for papers by Roberto Gastaldi Breakdown of academic impact, for papers by Johan Lanng Nielsen Breakdown of academic impact, for papers by Nasrollah T. Shahidi Breakdown of academic impact, for papers by Shigeki Ohtake
Rankless by CCL
2026